Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RVPH | US
0.05
4.07%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.28
1.23
1.28
1.20
Reviva Pharmaceuticals Holdings Inc. a clinical-stage biopharmaceutical company discovers develops and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system respiratory cardiovascular metabolic and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063) which is in Phase III clinical trials for the treatment of schizophrenia as well as completed Phase I clinical trials to treat bipolar disorder major depressive disorder attention"deficit/hyperactivity disorder behavioral and psychotic symptoms of dementia or Alzheimer's disease Parkinson's disease psychosis attention deficit hyperactivity disorder pulmonary arterial hypertension and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is based in Cupertino California."
View LessLow Market Beta (-0.4 to 0.8)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
61.7%1 month
76.7%3 months
144.7%6 months
123.7%-
-
8.35
-
-
-6.00
-
-
-10.10M
42.36M
42.36M
-
-
-
-
-1.80K
13.36
22.97
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.24
Range1M
0.46
Range3M
0.97
Rel. volume
0.89
Price X volume
279.54K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Immix Biopharma Inc. | IMMX | Biotechnology | 1.69 | 46.39M | 17.36% | n/a | 4.57% |
Rallybio Corporation Common Stock | RLYB | Biotechnology | 1.09 | 45.22M | -0.46% | n/a | 0.35% |
Lexaria Bioscience Corp | LEXX | Biotechnology | 2.83 | 44.74M | -1.39% | n/a | 1.41% |
Eyenovia Inc | EYEN | Biotechnology | 0.508 | 43.49M | -7.64% | n/a | -662.22% |
LAVA Therapeutics BV | LVTX | Biotechnology | 1.65 | 43.39M | 0.00% | n/a | 14.37% |
CALC | CALC | Biotechnology | 3.9595 | 42.57M | -4.36% | n/a | 0.00% |
Clene Nanomedicine Inc | CLNN | Biotechnology | 5.34 | 42.52M | -5.82% | n/a | -6472.02% |
HOOKIPA Pharma Inc | HOOK | Biotechnology | 4.17 | 41.93M | 6.92% | n/a | 5.69% |
Achilles Therapeutics plc American Depositary Shares | ACHL | Biotechnology | 0.99 | 41.78M | 0.00% | n/a | 3.86% |
CARM | CARM | Biotechnology | 0.9998 | 41.54M | 3.00% | n/a | 1044.17% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -6.00 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 8.35 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 144.74 | 72.92 | Riskier |
Debt to Equity | - | -1.24 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 42.36M | 3.78B | Emerging |